Zdrowie i gospodarka · 08/02/2008
FDA Announces Enforcement Action Against Unapproved Colchicine for Injection Products
The FDA is taking enforcement action against unapproved colchicine for injection products due to their potential for serious adverse events and narrow margin of safety, requiring manufacturers to obtain FDA approval for new drug applications.